The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations

Journal of Genetic Counseling

Volumn 13, Issue 3, 2004, Pages 237-257

  Kelly, Kimberly ^a   Leventhal, Howard ^b   Andrykowski, Michael ^a   Toppmeyer, Deborah ^c   Much, Judie ^c   Dermody, James ^d   Marvin, Monica ^e   Baran, Jill ^c   Schwalb, Marvin ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e SPECTRUM HEALTH   (United States)

Author keywords

BRCA1 2 testing; Breast cancer; Genetic counseling; Genetic testing; Ovarian cancer; Psychosocial factors; Risk perception

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICAL DECISION MAKING; ONCOGENE; OVARY CANCER; PATIENT INFORMATION; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; STATISTICAL ANALYSIS;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; JEWS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PROBABILITY; RELIGION AND MEDICINE; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 3543032176     PISSN: 10597700     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOGC.0000027959.37096.78     Document Type: Article

References (42)

1. Albarracin, D., Johnson, B. T., Fishbein, M., & Muellerleile, P. A. (2001). Theories of Reasoned Action and Planned Behavior as models of condom use: A meta-analysis. Psychol Bull, 127(1), 142-161.
2. Andrykowski, M. A., Lightner, R., Studts, J. L., & Munn, R. K. (1997). Hereditary cancer risk notification and testing: How interested is the general population? J Clin Oncol, 15(5), 2139-2148.
3. Beral, V., & Reeves, G. (1993). Childbearing, oral contraceptive use and breast cancer. Lancet, 34, 1102.
4. Bluman, L. G., Rimer, B. K., Berry, D. A., Borstelmann, N., Iglehart, J. D., Regan, K., et al. (1999). Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol, 17(3), 1040-1046.
5. Bodd, T. L., Reichelt, J., Heimdal, K., & Møller, P. (2003). Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns, 12(5), 405-417.
6. Burke, W., Culver, J. O., Bowen, D., Lowry, D., Durfy, S., McTiernan, A., et al. (2000). Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet, 90, 361-368.
7. Butow, P. N., Lobb, E. A., Meiser, B., Barratt, A., & Tucker, K. M. (2003). Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. Med J Aust, 178(2), 77-81.
8. Cappelli, M., Surh, L., Humphreys, L., Verma, S., Logan, D., Hunter, A., et al. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet, 55, 419-430.
9. Colditz, G. A., Willett, W. C., Hunter, D. J., Stampfer, M. J., Manson, J. E., Hennekens, C. H., et al. (1993). Family history, age, and risk of breast cancer. Prospective data from the Nurses Health Study. JAMA, 270, 1563-1568.
10. Cull, A., Anderson, E. D. C., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer, 79(3/4), 501-508.
11. Djurdjinovic, L. (1998). Psychosocial counseling. In D. L. Baker, J. L. Schuette, and W. R. Uhlmann (Eds.), A guide to genetic counseling (pp. 128-170). New York: Wiley-Liss.
12. Easton, D. F., Ford, D., Bishop, T., & Breast Cancer Linkage Consortium. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet, 56, 265-271.
13. Evans, D. G. R., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer, 70, 934-938.
14. Fioretti, F., Tavani, A., Bosetti, C., La Vecchia, C., Negri, E., Barbone, F., et al. (1999). Risk factors for breast cancer in nulliparous women. Br J Cancer, 79(11/12), 1923-1928.
15. Fitzgerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., et al. (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334(3), 143-149.
16. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., et al. (1989). Projecting inidividualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst, 81, 1879-1886.
17. Gwyn, K., Vernon, S. W., & Conoley, P. M. (2003). Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiol Biomarkers Prev, 12, 96-102.
18. Kelly, K., Leventhal, H., Toppmeyer, D., Much, J., Dermody, J., Marvin, M., et al. (2003). Subjective and objective risk of carrying a BRCA1/2 mutation in individuals of Ashkenazi Jewish descent. J Genet Couns, 12(4), 351-371.
19. Kessler, S. 1992. Psychological aspects of genetic counseling. VII. Thoughts of directiveness. J Genet Couns, 1, 9-17.
20. Kinney, A. Y., Croyle, R. T., Dudley, W. N., Bailey, C. A., Pelias, M. K., & Neuhausen, S. L. (2001). Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. Prev Med, 33, 543-551.
21. Lebo, M., & Nesselroade, J. (1978). Intraindividual differences dimensions of mood change during pregnancy identified in five P-technique factor analyses. J Res Pers, 12, 205-224.
22. Lee, S., Bernhardt, B. A., & Helzlsouer, K. J. (2002). Utilization of BRCA1/2 genetic testing in the clinical setting: Report from a single institution. Cancer, 94(6), 1876-1885.
23. Lerman, C., Biesecker, B. B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., et al. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst, 89(2), 148-157.
24. Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol, 12(4), 843-850.
25. Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. J Natl Cancer Inst, 87(4), 286-292.
26. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996a). BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA, 275(24 SP-1885), 1892.
27. Lerman, C., Schwartz, M., Miller, S., Daly, M., Sands, C., & Rimer, B. (1996b). A randomized trial of breast cancer risk counseling: Interacting effects of counseling, education level, and coping style. Health Psychol, 15(2), 75-83.
28. McNair, D., Lorr, M., & Droppleman, L. (1971). Profile of mood states. San Diego, CA: Educational and Industrial Testing Service.
29. McTiernan, A., & Thomas, D. B. (1986). Evidence of a protective effect of lactation on risk of breast cancer in young women. Results from a case control study. Am J Epidemiol, 124(3), 353-358.
30. Meiser, B. & Halliday, J. L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med, 54(10), 1463-1470.
31. National Society of Genetic Counselors. (2003). Retrieved from [Web Page] www.nsgc.org
32. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, et al. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet, 14, 188-190.
33. Parmigiani, G., Berry, D. A., & Aguilar, O. (1998). Modeling risk of breast cancer and decisions bout genetic testing. Am J Hum Genet, 62, 145-148.
34. Petersen, G. M., Larkin, E., Codori, A. M., Wang, C. Y., Booker, S. V., Bacon, J., et al. (1999). Attitudes toward colon cancer gene testing: Survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev, 8(4, P. 2), 337-344.
35. Randall, J., Butow, P., Kirk, J., & Tucker, K. (2001). Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Intern Med J, 31, 397-405.
36. Roa, B., Boyd, A., Volcik, K., & Richards, S. (1996). Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet, 14, 185-187.
37. Schwartz, M. D., Hughes, C., Roth, J., Main, D., Peshkin, B. N., Isaacs, C., et al. (2000). Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev, 9, 381-385.
38. Sheppard, M. A. (1989). Adolescents' perceptions of cannabis use by their peers: Does it have anything to do with behavior? J Drug Educ, 19(2), 157-164.
39. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med, 336(20), 1401-1408.
40. Struewing, J. P., Lerman, C., Kase, R., Giambarresi, T., & Tucker, M. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev, 4, 169-173.
41. Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T. R., Neuhausen, S., and et al. (1996). Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med, 2(11), 1179-1183.
42. Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., et al. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer, 79(5/6), 868-874.